Cargando…

Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma

B-cell receptor (BCR) and JAK/STAT pathways play critical roles in diffuse large B-cell lymphoma (DLBCL). Herein, we investigated the anti-lymphoma activity of cerdulatinib, a novel compound that dually targets SYK and JAK/STAT pathways. On a tissue microarray of 62 primary DLBCL tumors, 58% express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jiao, Xing, Wei, Coffey, Greg, Dresser, Karen, Lu, Kellie, Guo, Ailin, Raca, Gordana, Pandey, Anjali, Conley, Pamela, Yu, Hongbo, Wang, Y. Lynn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791274/ https://www.ncbi.nlm.nih.gov/pubmed/26575169

Ejemplares similares

Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment
por: Guo, Ailin, et al.
Publicado: (2017)

Comparison of the algorithms classifying the ABC and GCB subtypes in diffuse large B-cell lymphoma
por: Boltežar, Lučka, et al.
Publicado: (2018)

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker
por: Batlle-López, Ana, et al.
Publicado: (2016)

Simultaneous inhibition of JAK and SYK kinases ameliorates chronic and destructive arthritis in mice
por: Llop-Guevara, Alba, et al.
Publicado: (2015)

A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas
por: van der Meeren, L. E., et al.
Publicado: (2019)

Primary Type3 (Non-ABC, Non-GCB) Subtype of Extranodal Diffuse Large B-Cell Lymphoma of the Thyroid Bearing No MYD88 Mutation by Padlock Probe Hybridization
por: Nishi, Yukiko, et al.
Publicado: (2017)

Primary Cutaneous DLBCL Non-GCB Type: Challenges of a Rare Case
por: Sica, Antonello, et al.
Publicado: (2020)

Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement
por: Geng, Hongzhi, et al.
Publicado: (2023)

Sir Alfred Keogh, G.C.B., M.D.: The Director-General of the Army Medical Service
Publicado: (1917)

Sir Alfred Keogh, G.C.B. M.D.: Rector of the Imperial College of Science and Technology
Publicado: (1918)

Prognostic value of expression of nuclear factor kappa-B/p65 in non-GCB DLBCL patients
por: Wang, Jing, et al.
Publicado: (2016)

Germinal Center B Cell-Like (GCB) and Activated B Cell-Like (ABC) Type of Diffuse Large B Cell Lymphoma (DLBCL): Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival
por: Blenk, S., et al.
Publicado: (2007)

SYK Allelic Loss and the Role of Syk-Regulated Genes in Breast Cancer Survival
por: Blancato, Jan, et al.
Publicado: (2014)

RCSD1-ABL1 Translocation Associated with IKZF1 Gene Deletion in B-Cell Acute Lymphoblastic Leukemia
por: Kamran, Shawana, et al.
Publicado: (2015)

Targeting PIN-1 Attenuates GCB DLBCL Cell Proliferation Through Inhibition of PI3K/AKT Signaling
por: Yang, Haijun, et al.
Publicado: (2020)

Get Syk and get cycling
por: Williams, Ruth
Publicado: (2006)

Syk and Yea Shall Find
por: Wolozin, Benjamin, et al.
Publicado: (2015)

MYC Amplification in Angiosarcoma Arising from an Arteriovenous Graft Site
por: Paral, Kristen M., et al.
Publicado: (2015)

Cytogenetics Is a Science, Not a Technique! Why Optical Genome Mapping Is So Important to Clinical Genetic Laboratories
por: Smith, Adam C., et al.
Publicado: (2023)

Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma
por: Xu, Xin, et al.
Publicado: (2021)

Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis
por: Tsygankova, Svetlana, et al.
Publicado: (2022)

Postnatal Syk deletion in mice clarifies the function of Syk in an anti-collagen antibody-induced arthritis model
por: Ozaki, Naoko, et al.
Publicado: (2012)

GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner
por: Xia, Zhizhou, et al.
Publicado: (2021)

P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL
por: Qu, Chang-Ju, et al.
Publicado: (2023)

SYK expression in human breast cancer
por: Elkak, AE, et al.
Publicado: (2005)

Targeting Syk in Autoimmune Rheumatic Diseases
por: Deng, Guo-Min, et al.
Publicado: (2016)

Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T-cell lymphoma expressing the ITK-SYK fusion gene
por: Zhang, Lei-Lei, et al.
Publicado: (2019)

Barley has two peroxisomal ABC transporters with multiple functions in β-oxidation
por: Mendiondo, Guillermina M., et al.
Publicado: (2014)

Report to the Right Honourable Lord Panmure, G.C.B., &c., of the Proceedings of the Sanitary Commission Dispatched to the Seat of War in the East, 1855–6
Publicado: (1858)

Identification of BLNK and BTK as mediators of rituximab‐induced programmed cell death by CRISPR screens in GCB‐subtype diffuse large B‐cell lymphoma
por: Thomsen, Emil Aagaard, et al.
Publicado: (2020)

CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain
por: Cho, Junhun, et al.
Publicado: (2022)

The microtubule-associated protein tau is phosphorylated by Syk
por: Lebouvier, Thibaud, et al.
Publicado: (2008)

Syk-coupled C-type lectins in immunity
por: Kerrigan, Ann M., et al.
Publicado: (2011)

Half-wormhole in SYK with one time point
por: Mukhametzhanov, Baur
Publicado: (2021)

SYK Regulates mTOR Signaling in AML
por: Carnevale, Julia, et al.
Publicado: (2013)

Exploring the role of SYK in respiratory in vivo models
por: Caniga, Michael, et al.
Publicado: (2013)

Syk inhibitors in clinical development for hematological malignancies
por: Liu, Delong, et al.
Publicado: (2017)

A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant
por: La Fortune, Kristin, et al.
Publicado: (2013)

Piper cubeba L. Methanol Extract Has Anti-Inflammatory Activity Targeting Src/Syk via NF-κB Inhibition
por: Qomaladewi, Nurinanda Prisky, et al.
Publicado: (2019)

A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models
por: Zhang, Nannan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8jfm0425vcc717m9teajk2q103